Don't fight the trend of this stock.
They can close out early if the trade isn't going their way.
We answer recent reader questions about three of the biotech stocks we regularly cover.
Static doesn't work in this industry. Pipelines work.
Some stocks have stories that make them compelling.
Prices look set to test key resistance, and this time should see a breakout to the upside.
Both pharma companies are promising names that easily could become buyout targets.
Carrot-stick 'arrangement' with biotech is a fair tradeoff but will produce winners and losers.
Biotechnology was the star of the show.

A Play on Intel's Breakdown Real Money Pro($)

With trend favoring the bears, I'm favoring a bearish call spread.

Columnist Conversations

Shares of Exxon Mobil  (XOM) have been declining steadily this year, and moved back down to long term sup...
we'll go with this name on the massive flow today on the Apr 22 strike. BOUGHT QVCA APR 20 CALL AT 1....
Vacation company Norwegian Cruise Line Holdings (NCLH) posted improved results in its latest quarter.  ...
Nice move in GPS today. The stock is up 2.7% late in the session and is holding above last month's peak($24.93...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.